Publication | Open Access
Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial)
36
Citations
26
References
2018
Year
Domest TrialClinical TranslationImatinib Stop StudyMedicineClinical EndpointClinical TrialsTreatment OptionPharmacotherapyDrug TrialOncologyJapanese Clinical Setting
| Year | Citations | |
|---|---|---|
Page 1
Page 1